Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Akinduro OO, Izzo A, Lu VM, Ricciardi L, Trifiletti D, Peterson JL, Bernet V, Donaldson A, Eggenberger E, Olomu O, Reimer R, Wharen R, Quinones-Hinojosa A, Chaichana KL (2019) Endocrine and visual outcomes following gross total resection and subtotal resection of adult craniopharyngioma: systematic review and meta-analysis. World neurosurgery 127:e656–e668. https://doi.org/10.1016/j.wneu.2019.03.239
2. Barajas MA, Ramirez-Guzman G, Rodriguez-Vazquez C, Toledo-Buenrostro V, Velasquez-Santana H, del Robles RV, Cuevas-Solorzano A, Rodriguez-Hernandez G (2002) Multimodal management of craniopharyngiomas: neuroendoscopy, microsurgery, and radiosurgery. J Neurosurg 97:607–609. https://doi.org/10.3171/jns.2002.97.supplement
3. Brastianos PK, Twohy E, Geyer S, Gerstner ER, Kaufmann TJ, Tabrizi S, Kabat B, Thierauf J, Ruff MW, Bota DA, Reardon DA, Cohen AL, De La Fuente MI, Lesser GJ, Campian J, Agarwalla PK, Kumthekar P, Mann B, Vora S, Knopp M, Iafrate AJ, Curry WT Jr, Cahill DP, Shih HA, Brown PD, Santagata S, Barker FG 2nd, Galanis E (2023) BRAF-MEK inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med 389:118–126. https://doi.org/10.1056/NEJMoa2213329
4. Cinalli G, Spennato P, Cianciulli E, Fiorillo A, Di Maio S, Maggi G (2006) The role of transventricular neuroendoscopy in the management of craniopharyngiomas: three patient reports and review of the literature. J Pediatric Endocrinol Metab : JPEM 19(Suppl 1):341–354
5. Conti A, Pontoriero A, Ghetti I, Senger C, Vajkoczy P, Pergolizzi S, Germano A (2019) Benefits of image-guided stereotactic hypofractionated radiation therapy as adjuvant treatment of craniopharyngiomas. A Review Childs Nerv Syst 35:53–61. https://doi.org/10.1007/s00381-018-3954-z